Foster, Rachel H.; McClellan, Karen J. - In: PharmacoEconomics 16 (1999) 6, pp. 743-755
-dependent patients who have successfully undergone detoxification. Abstinence rates during 3 to 12 months' treatment with acamprosate … being diarrhoea. _ In a German cost-effectiveness model, a treatment programme including acamprosate was the dominant … with treatment without acamprosate. _ In a Belgian pharmacoeconomic model, total direct medical costs over 2 years were 21 …